ARCT - Arcturus up 5% as cystic fibrosis candidate gets additional funding
2023-09-26 12:37:33 ET
More on Arcturus Therapeutics
- Arcturus: mRNA Therapies For Rare Diseases Accelerate Towards Proof Of Concept
- Arcturus, CSL granted EU review for COVID vaccine
- Arcturus Therapeutics' joint venture, ARCALIS bags $115M from Japanese government
- Arcturus down 18% on disappointing Q2 results
- Arcturus: Interim Readout Of Rare Disease Data In Coming Months
For further details see:
Arcturus up 5% as cystic fibrosis candidate gets additional funding